Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
SA55 Injection
Sinovac Research and Development Co.,
COVID-19
1 trial -
SA55 nasal spray
Sinovac Research and Development Co.,
COVID-19
1 trial -
SAB-176
SAB Biotherapeutics
Influenza Type A
1 trial -
SAB-185
SAB Biotherapeutics
COVID-19
2 trials -
SAB-301
SAB Biotherapeutics
Middle East Respiratory Syndrome Coronavirus
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
3 trials -
SAM-315
Wyeth is now a wholly owned subsidiary of Pfizer
Alzheimer Disease
1 trial -
SAR231893 (REGN668)
Regeneron UK Limited
Healthy
1 trial -
SAR231893 (REGN668) DP1
Regeneron UK Limited
Healthy
1 trial -
SAR441000
Atrium Therapeutics
Metastatic Neoplasm
1 trial -
SAR447971 first-in-human study
Sanofi-aventis Healthcare Pty Ltd
Hidradenitis
1 trial -
SAR448501
Sanofi Pasteur
B-cell Non Hodgkin Lymphoma
1 trial -
SC291
Sana Biotechnology
Lupus Erythematosus
1 trial -
SC291
Sana Biotechnology
Non Hodgkin Lymphoma
1 trial -
SCT-001 CAR-T cells
Shanghai University of Traditional Chinese Medicine
Ovarian Cancer
1 trial -
SCT510
The First People's Hospital of Lianyungang
Healthy
1 trial -
SER-214
Serina Therapeutics
Parkinson's Disease
1 trial -
SGT-212
Solid Biosciences
Friedreich's Ataxia (FA)
1 trial -
SGT-501
Solid Biosciences
Catecholaminergic Polymorphic Ventricular Tachycardia
1 trial -
SHP465 12.5mg
Takeda
Attention Deficit Hyperactivity Disorder (ADHD)
1 trial -
SHP681
Takeda
Healthy Volunteers
1 trial -
SHR-1501
Jian Li
Advanced Malignancies
1 trial -
SHR1459 tablet
Jian Li
B-cell Tumors
1 trial -
SIBP-A13 formulation for injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Solid Tumor
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources